Underlying hemodynamic differences are associated with responses to tilt testing
暂无分享,去创建一个
G. Parati | M. Brignole | R. Sutton | A. Ungar | B. Olshansky | A. Fedorowski | G. Rivasi | I. Marozzi | M. Rafanelli | V. Hamrefors | M. Johansson | P. Torabi | A. Ceccofiglio | N. Casini | Madeleine Johansson | Alice Ceccofiglio
[1] J. Sundquist,et al. Risk Factors for Syncope Associated With Multigenerational Relatives With a History of Syncope , 2021, JAMA network open.
[2] C. Morillo,et al. Low-blood pressure phenotype underpins the tendency to reflex syncope , 2021, Journal of hypertension.
[3] C. Morillo,et al. Low blood pressure phenotype underpins the tendency to reflex syncope , 2020, medRxiv.
[4] J. G. van Dijk,et al. Novel Methods for Quantification of Vasodepression and Cardioinhibition During Tilt-Induced Vasovagal Syncope , 2020, Circulation research.
[5] O. Melander,et al. Cardiovascular biomarkers and echocardiographic findings at rest and during graded hypovolemic stress in women with recurrent vasovagal syncope , 2019, Journal of cardiovascular electrophysiology.
[6] O. Melander,et al. Impact of Cardiovascular Neurohormones on Onset of Vasovagal Syncope Induced by Head‐up Tilt , 2019, Journal of the American Heart Association.
[7] J. Newton,et al. Hemodynamic Response to the Head-Up Tilt Test in Patients With Syncope as a Predictor of the Test Outcome: A Meta-Analysis Approach , 2019, Front. Physiol..
[8] L. Chen,et al. Greater early epinephrine rise with head‐up posture: A marker of increased syncope susceptibility in vasovagal fainters , 2018, Journal of cardiovascular electrophysiology.
[9] Corrigendum to: 2018 ESC/ESH Guidelines for the management of arterial hypertension. , 2018, European heart journal.
[10] Λίλιαν Μάντζιαρη,et al. 2018 ESC Guidelines for the diagnosis and management of syncope. , 2018, Revista espanola de cardiologia.
[11] O. Melander,et al. Monitoring of cerebral oximetry during head-up tilt test in adults with history of syncope and orthostatic intolerance , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[12] G. Lip,et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. , 2018, European heart journal.
[13] Christophe Leclercq,et al. 2018 ESC Guidelines for the diagnosis and management of syncope , 2018, European heart journal.
[14] B. Olshansky,et al. Pacing for Vasovagal Syncope. , 2018, Arrhythmia & electrophysiology review.
[15] M. Brignole,et al. The pathophysiology of the vasovagal response. , 2017, Heart rhythm.
[16] P. Alboni,et al. Typical vasovagal syncope as a “defense mechanism” for the heart by contrasting sympathetic overactivity , 2017, Clinical Autonomic Research.
[17] M. Brignole,et al. Stop vasodepressor drugs in reflex syncope: a randomised controlled trial , 2016, Heart.
[18] O. Melander,et al. Spontaneous vs nitroglycerin-induced vasovagal reflex on head-up tilt: Are there neuroendocrine differences? , 2016, Heart rhythm.
[19] R. Sutton. Rethinking Tilt Testing , 2016 .
[20] J. Blanc,et al. Vasovagal syncope in humans and protective reactions in animals. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[21] M. Brignole,et al. Twenty-eight years of research permit reinterpretation of tilt-testing: hypotensive susceptibility rather than diagnosis. , 2014, European heart journal.
[22] J. Deharo,et al. Benefit of Pacemaker Therapy in Patients With Presumed Neurally Mediated Syncope and Documented Asystole Is Greater When Tilt Test Is Negative: An Analysis From the Third International Study on Syncope of Uncertain Etiology (ISSUE-3) , 2014, Circulation. Arrhythmia and electrophysiology.
[23] M. Brignole,et al. Diagnosis of neurally mediated syncope at initial evaluation and with tilt table testing compared with that revealed by prolonged ECG monitoring. An analysis from the Third International Study on Syncope of Uncertain Etiology (ISSUE-3) , 2013, Heart.
[24] J. Kron. F1000Prime recommendation of Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial. , 2012 .
[25] J. Blanc,et al. Pacemaker Therapy in Patients With Neurally Mediated Syncope and Documented Asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3) A Randomized Trial , 2012, Circulation.
[26] J. Geddes,et al. What is a randomised controlled trial? , 2009, Epidemiologia e Psichiatria Sociale.
[27] Wouter Wieling,et al. Nexfin noninvasive continuous blood pressure validated against Riva-Rocci/Korotkoff. , 2009, American journal of hypertension.
[28] Mark Linzer,et al. Lifetime Cumulative Incidence of Syncope in the General Population: A Study of 549 Dutch Subjects Aged 35–60 Years , 2006, Journal of cardiovascular electrophysiology.
[29] Jamil Mayet,et al. Cardiac and vascular pathophysiology in hypertension , 2003, Heart.
[30] R. Sutton,et al. Pacing for Vasovagal Syncope. , 2018, Arrhythmia & electrophysiology review.
[31] M. Brignole,et al. 'The Italian Protocol': a simplified head-up tilt testing potentiated with oral nitroglycerin to assess patients with unexplained syncope. , 2000, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[32] W. White,et al. Heart rate and the rate-pressure product as determinants of cardiovascular risk in patients with hypertension. , 1998, American journal of hypertension.
[33] N. Stergiopulos,et al. Determinants of stroke volume and systolic and diastolic aortic pressure. , 1996, The American journal of physiology.
[34] R. Kenny,et al. HEAD-UP TILT: A USEFUL TEST FOR INVESTIGATING UNEXPLAINED SYNCOPE , 1986, The Lancet.
[35] K H Wesseling,et al. Why use Finapres or Portapres rather than intra-arterial or intermittent non-invasive techniques of blood pressure measurement? , 1998, Journal of medical engineering & technology.